22 January 2025
COLEFAX GROUP PLC (“Colefax” or the “Group”) Half Year Results for the six months ended 31 October 2024 Colefax is an international designer and…
21 January 2025
Financial Report Tom Burnet, Chair of the Company commented: “We are pleased to present the Company’s Interim Financial Report for a highly successful period…
21 January 2025 Cranswick plc (“Cranswick” or “the Company” or “the Group”) Third quarter trading statement and Acquisition of JSR Genetics, a leading UK…
Full Year Trading Update and Notice of Results Marshalls, a leading manufacturer of sustainable solutions for the built environment, provides the following trading update…
20 January 2025
20 January 2025 Datroway (datopotamab deruxtecan) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer First approval in the US…
M. P. EVANS GROUP PLC (“THE GROUP”)2024 crop and production M.P. Evans Group PLC, a producer of sustainable Indonesian palm oil, is pleased to…
European Commission expands Jemperli (dostarlimab) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer · Expanded approval includes MMRp/MSS tumours, which represent…
17 January 2025
Two of London’s FTSE 100 heavyweight miners are reported to be in early stage talks about a merger that would create a commodities giant…